Literature DB >> 25562060

Outpatient parenteral antibiotic therapy in an academic practice in Rhode Island.

Francine Touzard Romo, Brian Resnick, Mildred Perez-Cioe, Timothy P Flanigan, Erna M Kojic, Curt G Beckwith.   

Abstract

Outpatient parenteral antimicrobial therapy (OPAT) is an increasingly utilized treatment modality that has been proven to be safe and cost effective for treating infections that require prolonged antimicrobial treatment. Adequate patient selection, a structured OPAT team with an effective communication system, and routine clinical monitoring are key elements to establish a successful OPAT program. The Miriam Hospital Infectious Diseases Clinic offers a multidisciplinary OPAT model coordinated by infectious diseases specialists and serves as a major referral center in Rhode Island.

Entities:  

Keywords:  OPAT; Rhode Island; antibiotics; infection

Mesh:

Substances:

Year:  2014        PMID: 25562060      PMCID: PMC4357256     

Source DB:  PubMed          Journal:  R I Med J (2013)        ISSN: 0363-7913


  14 in total

1.  Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines.

Authors:  Alan D Tice; Susan J Rehm; Joseph R Dalovisio; John S Bradley; Lawrence P Martinelli; Donald R Graham; R Brooks Gainer; Mark J Kunkel; Robert W Yancey; David N Williams
Journal:  Clin Infect Dis       Date:  2004-05-26       Impact factor: 9.079

2.  Serum C-reactive protein, erythrocyte sedimentation rate and white blood cell count in septic arthritis of children.

Authors:  M J Kallio; L Unkila-Kallio; K Aalto; H Peltola
Journal:  Pediatr Infect Dis J       Date:  1997-04       Impact factor: 2.129

3.  Practical considerations in the use of outpatient antimicrobial therapy for musculoskeletal infections.

Authors:  Camelia E Marculescu; Elie F Berbari; J Robert Cantey; Douglas R Osmon
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

4.  Outpatient intravenous medications in the management of cystic fibrosis.

Authors:  R W Rucker; G M Harrison
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

Review 5.  Outpatient parenteral antimicrobial therapy today.

Authors:  Joseph A Paladino; Donald Poretz
Journal:  Clin Infect Dis       Date:  2010-09-15       Impact factor: 9.079

6.  Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center.

Authors:  Brett H Heintz; Jenana Halilovic; Cinda L Christensen
Journal:  Ann Pharmacother       Date:  2011-10-11       Impact factor: 3.154

7.  Peripherally inserted central catheters in general medicine.

Authors:  P K Ng; M J Ault; A G Ellrodt; L Maldonado
Journal:  Mayo Clin Proc       Date:  1997-03       Impact factor: 7.616

8.  Serial serum C-reactive protein to monitor recovery from acute hematogenous osteomyelitis in children.

Authors:  I Roine; I Faingezicht; A Arguedas; J F Herrera; F Rodríguez
Journal:  Pediatr Infect Dis J       Date:  1995-01       Impact factor: 2.129

Review 9.  Clinical recognition and diagnosis of Clostridium difficile infection.

Authors:  John G Bartlett; Dale N Gerding
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

Review 10.  Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis.

Authors:  Susanne Hempel; Sydne J Newberry; Alicia R Maher; Zhen Wang; Jeremy N V Miles; Roberta Shanman; Breanne Johnsen; Paul G Shekelle
Journal:  JAMA       Date:  2012-05-09       Impact factor: 56.272

View more
  2 in total

Review 1.  Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?

Authors:  Ester Steffens; Charlotte Quintens; Inge Derdelinckx; Willy E Peetermans; Johan Van Eldere; Isabel Spriet; Annette Schuermans
Journal:  Infection       Date:  2018-11-15       Impact factor: 3.553

2.  Outpatient Parenteral Therapy for Complicated Staphylococcus aureus Infections: A Snapshot of Processes and Outcomes in the Real World.

Authors:  Jennifer Townsend; Sara Keller; Martin Tibuakuu; Sameer Thakker; Bailey Webster; Maya Siegel; Kevin J Psoter; Omar Mansour; Trish M Perl
Journal:  Open Forum Infect Dis       Date:  2018-10-24       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.